|
EP1001986A2
|
|
Pharmaceuticals for modulating hormone responsiveness
|
|
WO9905172A2
|
|
Pharmaceuticals for modulating hormone responsiveness
|
|
WO9848003A1
|
|
Calreticulin-deficient cells
|
|
WO9723625A1
|
|
Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
|
|
AU3920395A
|
|
New pharmaceuticals for modulating hormone responsiveness
|
|
CA2140814A1
|
|
Use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease
|
